Increased NY-ESO-1 Expression and Reduced Infiltrating CD3+ T Cells in Cutaneous Melanoma
NY-ESO-1 is a cancer-testis antigen aberrantly expressed in melanomas, which may serve as a robust and specific target in immunotherapy. NY-ESO-1 antigen expression, tumor features, and the immune profile of tumor infiltrating lymphocytes were assessed in primary cutaneous melanoma. NY-ESO-1 protein...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2015-01-01
|
| Series: | Journal of Immunology Research |
| Online Access: | http://dx.doi.org/10.1155/2015/761378 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849306414059618304 |
|---|---|
| author | Mara Giavina-Bianchi Pedro Giavina-Bianchi Mirian Nacagami Sotto Alona Muzikansky Jorge Kalil Cyro Festa-Neto Lyn M. Duncan |
| author_facet | Mara Giavina-Bianchi Pedro Giavina-Bianchi Mirian Nacagami Sotto Alona Muzikansky Jorge Kalil Cyro Festa-Neto Lyn M. Duncan |
| author_sort | Mara Giavina-Bianchi |
| collection | DOAJ |
| description | NY-ESO-1 is a cancer-testis antigen aberrantly expressed in melanomas, which may serve as a robust and specific target in immunotherapy. NY-ESO-1 antigen expression, tumor features, and the immune profile of tumor infiltrating lymphocytes were assessed in primary cutaneous melanoma. NY-ESO-1 protein was detected in 20% of invasive melanomas (16/79), rarely in in situ melanoma (1/10) and not in benign nevi (0/20). Marked intratumoral heterogeneity of NY-ESO-1 protein expression was observed. NY-ESO-1 expression was associated with increased primary tumor thickness (P=0.007) and inversely correlated with superficial spreading melanoma (P<0.02). NY-ESO-1 expression was also associated with reduced numbers and density of CD3+ tumor infiltrating lymphocytes (P=0.017). When NY-ESO-1 protein was expressed, CD3+ T cells were less diffusely infiltrating the tumor and were more often arranged in small clusters (P=0.010) or as isolated cells (P=0.002) than in large clusters of more than five lymphocytes. No correlation of NY-ESO-1 expression with gender, age, tumor site, ulceration, lymph node sentinel status, or survival was observed. NY-ESO-1 expression in melanoma was associated with tumor progression, including increased tumor thickness, and with reduced tumor infiltrating lymphocytes. |
| format | Article |
| id | doaj-art-34c139a5ee5644c99b1a8b349e9265e5 |
| institution | Kabale University |
| issn | 2314-8861 2314-7156 |
| language | English |
| publishDate | 2015-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Journal of Immunology Research |
| spelling | doaj-art-34c139a5ee5644c99b1a8b349e9265e52025-08-20T03:55:06ZengWileyJournal of Immunology Research2314-88612314-71562015-01-01201510.1155/2015/761378761378Increased NY-ESO-1 Expression and Reduced Infiltrating CD3+ T Cells in Cutaneous MelanomaMara Giavina-Bianchi0Pedro Giavina-Bianchi1Mirian Nacagami Sotto2Alona Muzikansky3Jorge Kalil4Cyro Festa-Neto5Lyn M. Duncan6Department of Dermatology, University of São Paulo, Avenida Dr. Enéas de Carvalho Aguiar 255, 3° Andar, 05403-900 São Paulo, SP, BrazilDivision of Clinical Immunology and Allergy, University of São Paulo, Avenida Dr. Enéas de Carvalho Aguiar 255, 8° Andar, 05403-900 São Paulo, SP, BrazilDepartment of Dermatology, University of São Paulo, Avenida Dr. Enéas de Carvalho Aguiar 255, 3° Andar, 05403-900 São Paulo, SP, BrazilMGH Biostatistics Center, 50 Staniford Street, Suite 560, Boston, MA 02114, USADivision of Clinical Immunology and Allergy, University of São Paulo, Avenida Dr. Enéas de Carvalho Aguiar 255, 8° Andar, 05403-900 São Paulo, SP, BrazilDepartment of Dermatology, University of São Paulo, Avenida Dr. Enéas de Carvalho Aguiar 255, 3° Andar, 05403-900 São Paulo, SP, BrazilDermatopathology Unit, Pathology Service, Massachusetts General Hospital, Harvard Medical School, Warren Building 825, 55 Fruit Street, Boston, MA 02114, USANY-ESO-1 is a cancer-testis antigen aberrantly expressed in melanomas, which may serve as a robust and specific target in immunotherapy. NY-ESO-1 antigen expression, tumor features, and the immune profile of tumor infiltrating lymphocytes were assessed in primary cutaneous melanoma. NY-ESO-1 protein was detected in 20% of invasive melanomas (16/79), rarely in in situ melanoma (1/10) and not in benign nevi (0/20). Marked intratumoral heterogeneity of NY-ESO-1 protein expression was observed. NY-ESO-1 expression was associated with increased primary tumor thickness (P=0.007) and inversely correlated with superficial spreading melanoma (P<0.02). NY-ESO-1 expression was also associated with reduced numbers and density of CD3+ tumor infiltrating lymphocytes (P=0.017). When NY-ESO-1 protein was expressed, CD3+ T cells were less diffusely infiltrating the tumor and were more often arranged in small clusters (P=0.010) or as isolated cells (P=0.002) than in large clusters of more than five lymphocytes. No correlation of NY-ESO-1 expression with gender, age, tumor site, ulceration, lymph node sentinel status, or survival was observed. NY-ESO-1 expression in melanoma was associated with tumor progression, including increased tumor thickness, and with reduced tumor infiltrating lymphocytes.http://dx.doi.org/10.1155/2015/761378 |
| spellingShingle | Mara Giavina-Bianchi Pedro Giavina-Bianchi Mirian Nacagami Sotto Alona Muzikansky Jorge Kalil Cyro Festa-Neto Lyn M. Duncan Increased NY-ESO-1 Expression and Reduced Infiltrating CD3+ T Cells in Cutaneous Melanoma Journal of Immunology Research |
| title | Increased NY-ESO-1 Expression and Reduced Infiltrating CD3+ T Cells in Cutaneous Melanoma |
| title_full | Increased NY-ESO-1 Expression and Reduced Infiltrating CD3+ T Cells in Cutaneous Melanoma |
| title_fullStr | Increased NY-ESO-1 Expression and Reduced Infiltrating CD3+ T Cells in Cutaneous Melanoma |
| title_full_unstemmed | Increased NY-ESO-1 Expression and Reduced Infiltrating CD3+ T Cells in Cutaneous Melanoma |
| title_short | Increased NY-ESO-1 Expression and Reduced Infiltrating CD3+ T Cells in Cutaneous Melanoma |
| title_sort | increased ny eso 1 expression and reduced infiltrating cd3 t cells in cutaneous melanoma |
| url | http://dx.doi.org/10.1155/2015/761378 |
| work_keys_str_mv | AT maragiavinabianchi increasednyeso1expressionandreducedinfiltratingcd3tcellsincutaneousmelanoma AT pedrogiavinabianchi increasednyeso1expressionandreducedinfiltratingcd3tcellsincutaneousmelanoma AT miriannacagamisotto increasednyeso1expressionandreducedinfiltratingcd3tcellsincutaneousmelanoma AT alonamuzikansky increasednyeso1expressionandreducedinfiltratingcd3tcellsincutaneousmelanoma AT jorgekalil increasednyeso1expressionandreducedinfiltratingcd3tcellsincutaneousmelanoma AT cyrofestaneto increasednyeso1expressionandreducedinfiltratingcd3tcellsincutaneousmelanoma AT lynmduncan increasednyeso1expressionandreducedinfiltratingcd3tcellsincutaneousmelanoma |